The Asia Pacific Neuroscience Market should witness market growth of 6.2% CAGR during the forecast period (2023-2030).
Neuro-microscopy, electrophysiology, neuro-cellular manipulation, whole-brain imaging, and other techniques are the main neurosciences categories offered through tools, supplies, software, and services. A neuro-microscope is designed specifically for brain, spinal cord, and spine surgery. The neuro-microscopy, which has a binocular head with movable eyepieces and foot controls to enable arm mobility, is used to illuminate and magnify the deeper regions of the relevant field. Hospitals, diagnostic centres, research facilities, and academic institutions all employ neuroscience.
The development of neuroscience-related algorithms, ongoing brain mapping research and investigation projects, government-led neuroscience initiatives, and other factors are projected to further fuel the expansion of the market. These elements will encourage product acceptance in this market, increasing revenue creation throughout the projected period. While two-photon microscopy in conjunction with optogenetics-based simulation technology is anticipated to grow quickly as an emerging sector, light and electron microscope neuron imaging techniques have been used for study for longer periods. The market is also expected to develop due to the significantly high number of goods and services available for behaviour study using different animal models.
The percentage of non-communicable neurological disorders in India’s total disability-adjusted life-years (DALYs) has increased from 4.0% in 1990 to 8.2% in 2019. The top neurological disorders causing DALYs in India in 2019 were stroke, headache disorders, epilepsy, cerebral palsy, and encephalitis. In 2019, there was significant heterogeneity in the crude DALY rate of various neurological disorders across different states. The disorders with the highest variation were tetanus, meningitis, and stroke. The growing prevalence of neurological diseases is expected to increase the market for the treatment of such diseases. Moreover, the rising R&D and the advancement of the technologies are expected to increase the adoption for neuro microscopy devices, boosting the market growth in the region.
The China market dominated the Asia Pacific Neuroscience Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,951.5 million by 2030. The Japan market is registering a CAGR of 5.5% during (2023-2030). Additionally, India's market would showcase a CAGR of 6.9% during (2023-2030).
Based on Component, the market is segmented into Instruments, Consumables, and Software & Services. Based on Technology, the market is segmented into Brain Imaging, Stereotaxic Surgeries, Neuro-Microscopy, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation, and Others. Based on End-user, the market is segmented into Diagnostic Laboratories, Hospitals, and Research & Academic Institute. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Carl Zeiss AG, Danaher Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Terumo Corporation, B. Braun Melsungen AG, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories
Neuro-microscopy, electrophysiology, neuro-cellular manipulation, whole-brain imaging, and other techniques are the main neurosciences categories offered through tools, supplies, software, and services. A neuro-microscope is designed specifically for brain, spinal cord, and spine surgery. The neuro-microscopy, which has a binocular head with movable eyepieces and foot controls to enable arm mobility, is used to illuminate and magnify the deeper regions of the relevant field. Hospitals, diagnostic centres, research facilities, and academic institutions all employ neuroscience.
The development of neuroscience-related algorithms, ongoing brain mapping research and investigation projects, government-led neuroscience initiatives, and other factors are projected to further fuel the expansion of the market. These elements will encourage product acceptance in this market, increasing revenue creation throughout the projected period. While two-photon microscopy in conjunction with optogenetics-based simulation technology is anticipated to grow quickly as an emerging sector, light and electron microscope neuron imaging techniques have been used for study for longer periods. The market is also expected to develop due to the significantly high number of goods and services available for behaviour study using different animal models.
The percentage of non-communicable neurological disorders in India’s total disability-adjusted life-years (DALYs) has increased from 4.0% in 1990 to 8.2% in 2019. The top neurological disorders causing DALYs in India in 2019 were stroke, headache disorders, epilepsy, cerebral palsy, and encephalitis. In 2019, there was significant heterogeneity in the crude DALY rate of various neurological disorders across different states. The disorders with the highest variation were tetanus, meningitis, and stroke. The growing prevalence of neurological diseases is expected to increase the market for the treatment of such diseases. Moreover, the rising R&D and the advancement of the technologies are expected to increase the adoption for neuro microscopy devices, boosting the market growth in the region.
The China market dominated the Asia Pacific Neuroscience Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,951.5 million by 2030. The Japan market is registering a CAGR of 5.5% during (2023-2030). Additionally, India's market would showcase a CAGR of 6.9% during (2023-2030).
Based on Component, the market is segmented into Instruments, Consumables, and Software & Services. Based on Technology, the market is segmented into Brain Imaging, Stereotaxic Surgeries, Neuro-Microscopy, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation, and Others. Based on End-user, the market is segmented into Diagnostic Laboratories, Hospitals, and Research & Academic Institute. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Carl Zeiss AG, Danaher Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Terumo Corporation, B. Braun Melsungen AG, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories
Scope of the Study
By Component
- Instruments
- Consumables
- Software & Services
By Technology
- Brain Imaging
- Stereotaxic Surgeries
- Neuro-Microscopy
- Neuro-Proteomic Analysis
- Neuro-Cellular Manipulation
- Others
By End-user
- Diagnostic Laboratories
- Hospitals
- Research & Academic Institute
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Carl Zeiss AG
- Danaher Corporation
- Koninklijke Philips N.V.
- GE HealthCare Technologies, Inc.
- Terumo Corporation
- B. Braun Melsungen AG
- Medtronic PLC
- Stryker Corporation
- Boston Scientific Corporation
- Abbott Laboratories
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Neuroscience Market by Component
Chapter 6. Asia Pacific Neuroscience Market by Technology
Chapter 7. Asia Pacific Neuroscience Market by End User
Chapter 8. Asia Pacific Neuroscience Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Carl Zeiss AG
- Danaher Corporation
- Koninklijke Philips N.V.
- GE HealthCare Technologies, Inc.
- Terumo Corporation
- B. Braun Melsungen AG
- Medtronic PLC
- Stryker Corporation
- Boston Scientific Corporation
- Abbott Laboratories
Methodology
LOADING...
